Key result
Sodium hydroxyethylene diphosphonate reduces platelet deposition but not calcium content on bovine pericardial valves.
Why the study?
Does sodium hydroxyethylene diphosphonate reduce platelet deposition and calcification on bovine pericardial valves in calves?
Population
Healthy adult mongrel dogs and calves undergoing mitral valve replacement with a bovine pericardial valve
Comparison
Sodium hydroxyethylene diphosphonate (5 mg kg-1 day-1 s.c.) vs untreated in calves
Design
Animal experimental study
Follow-up
30 days
Authors
Loading...
Diphosphonate may not prevent early bioprosthetic calcification despite reducing platelet deposition; leaves open platelet-independent mineralization pathways.
Does sodium hydroxyethylene diphosphonate reduce platelet deposition and calcification on bovine pericardial valves in calves?
Sodium hydroxyethylene diphosphonate reduces platelet deposition but not calcification on bovine pericardial valves in a calf model at 30 days.
Dewanjee et al. (1984) studied Mitral valve replacement. Sodium hydroxyethylene diphosphonate vs. Untreated calves was evaluated on Platelet deposition and calcium content on the valves. Sodium hydroxyethylene diphosphonate reduced platelet deposition but did not reduce calcium content on bovine pericardial valves at 30 days compared with untreated calves.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: